Phase 3 and Extension Trials With Ozanimod Therapy on Cortical Grey Matter Volume
The researchers evaluated the size and duration of interferon-induced changes in cortical grey matter volume (CGMV) for a study. In addition, they examined the long-term effects of switching to ozanimod in relapsing multiple...
Read More